The immunopathogenesis of human immunodeficiency virus infection.
暂无分享,去创建一个
A. Fauci | G. Pantaleo | G Pantaleo | C Graziosi | A S Fauci | C. Graziosi | A. Fauci | Giuseppe Pantaleo | Cecilia Graziosi
[1] R. Detels,et al. The Acquired Immunodeficiency Syndrome , 1983 .
[2] W. Frankel,et al. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice , 1991, Nature.
[3] T. Klimkait,et al. In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes. , 1991, Journal of immunology.
[4] D. Markovitz,et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.
[5] M. Malim,et al. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes , 1991, The Journal of experimental medicine.
[6] N. Brousse,et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.
[7] A. Fauci,et al. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission , 1991, The Journal of experimental medicine.
[8] M. Puoti,et al. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. , 1991, Science.
[9] D. Richman,et al. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro , 1989, The Journal of experimental medicine.
[10] E. Palmer,et al. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. , 1990, Science.
[11] J. Sidtis,et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.
[12] A. Fauci,et al. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. , 1991, Annals of the New York Academy of Sciences.
[13] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[14] J. Armstrong,et al. Retroviral infection of accessory cells and the immunological paradox in AIDS. , 1985, Immunology today.
[15] A. Wyllie,et al. Death and the cell. , 1986, Immunology today.
[16] G. Linette,et al. HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. , 1988, Science.
[17] Edgar G. Engleman,et al. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane , 1987, Cell.
[18] M. Cronin,et al. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] N. Yamamoto,et al. Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. , 1990, Biochemical and biophysical research communications.
[20] J Leibowitch,et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). , 1983, Science.
[21] D. Burke,et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.
[22] B. Cullen,et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.
[23] J. Habeshaw,et al. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. , 1990, Immunology today.
[24] J. Levy,et al. The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. , 1989, Disease markers.
[25] D. Richman,et al. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. , 1991, The Journal of clinical investigation.
[26] A. Fauci,et al. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.
[27] J. Wasserman,et al. Immunological changes in primary HIV‐1 infection , 1990, AIDS.
[28] A. Capron,et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.
[29] E. Werner,et al. Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. , 1989, Journal of acquired immune deficiency syndromes.
[30] S. Nakamura,et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. , 1992, Science.
[31] R. Axel,et al. HIV infection does not require endocytosis of its receptor, CD4 , 1988, Cell.
[32] W. O'brien,et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. , 1988, Science.
[33] J. Salmon,et al. Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. , 1990, Biochemical and biophysical research communications.
[34] I. Weissman,et al. Mouse lymph node germinal centers contain a selected subset of T cells--the helper phenotype. , 1982, Journal of immunology.
[35] W. Haseltine,et al. Molecular biology of the human immunodeficiency virus type 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[37] F. Miedema,et al. Non‐mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription , 1991, European journal of immunology.
[38] A. Fauci,et al. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. , 1990, Journal of immunology.
[39] P. Marrack,et al. Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.
[40] C. Rosen,et al. HIV regulatory proteins: potential targets for therapeutic intervention. , 1992, AIDS research and human retroviruses.
[41] A. Fauci,et al. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 , 1991, The Journal of experimental medicine.
[42] R. Schooley,et al. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. , 1987, AIDS research and human retroviruses.
[43] A. Cerami,et al. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses , 1988, The Journal of cell biology.
[44] S. Salahuddin,et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.
[45] A. Fauci,et al. The effect of cytokines and pharmacologic agents on chronic HIV infection. , 1992, AIDS research and human retroviruses.
[46] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[47] J. Justement,et al. Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. Orrenius,et al. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. , 1989, Journal of immunology.
[49] A. Fauci,et al. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.
[50] C A Smith,et al. Antigen‐induced apoptosis in developing t cells: a mechanism for negative selection of the t cell receptor repertoire* , 1989, European journal of immunology.
[51] M. Patarroyo,et al. The leukocyte adhesion glycoprotein CD18 participates in HIV-1-induced syncytia formation in monocytoid and T cells. , 1990, Journal of immunology.
[52] P. Wilkinson,et al. Lymphocyte locomotion and migration. , 1981, Progress in allergy.
[53] J. Zack,et al. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle , 1992, Journal of virology.
[54] C. Fox,et al. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. , 1991, Journal of immunology.
[55] P. Marrack,et al. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus , 1991, Nature.
[56] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Pabst,et al. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? , 1990, Immunology today.
[58] H. Gendelman,et al. Interferons in the persistence, pathogenesis, and treatment of HIV infection. , 1992, AIDS research and human retroviruses.
[59] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[60] J. Justement,et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Baseler,et al. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. , 1991, Journal of immunology.
[62] W. Blattner,et al. HIV causes AIDS. , 1988, Science.
[63] J. Hoxie,et al. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.
[64] G. F. Burton,et al. Follicular Dendritic Cells as Accessory Cells , 1990, Immunological reviews.
[65] A. Fauci,et al. In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. , 1990, Journal of immunology.
[66] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[67] G. Williams,et al. Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT. , 1989, Journal of interferon research.
[68] J. Phair,et al. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS , 1991, The Lancet.
[69] D. Montefiori,et al. Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. , 1989, Journal of acquired immune deficiency syndromes.
[70] J. Mcdougal,et al. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. , 1985, Journal of immunology.
[71] O. Strannegard,et al. Zidovudine in the management of primary HIV‐1 infection , 1991, AIDS.
[72] R. Redfield,et al. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease , 1992, Journal of virology.
[73] J. Sodroski,et al. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.
[74] H. Stein,et al. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. , 1992, The American journal of pathology.
[75] A. Fauci,et al. Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. , 1991, Journal of immunology.
[76] M. Greaves,et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.
[77] C. Janeway. MIs: makes a little sense , 1991, Nature.
[78] P. Marrack,et al. A maternally inherited superantigen encoded by a mammary tumour virus , 1991, Nature.
[79] D. Golde,et al. Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. , 1990, Blood.
[80] D. Ho,et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.
[81] R. Mittler,et al. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. , 1989, Science.
[82] J. Gerdes,et al. Isolation of normal human follicular dendritic cells and CD4‐independent in vitro infection by human immunodeficiency virus (HIV‐1) , 1991, European journal of immunology.
[83] C. Fox,et al. Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection , 1991, European journal of immunology.
[84] A. Fauci,et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.
[85] K. Kalland,et al. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[86] H. Gendelman,et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.
[87] H. Gendelman,et al. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[88] P. Luciw,et al. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. , 1989, Journal of immunology.
[89] A. Fauci,et al. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. , 1989, AIDS research and human retroviruses.
[90] E. Palmer,et al. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells , 1989, The Journal of experimental medicine.
[91] P. Marrack,et al. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex , 1988, Nature.
[92] A. Fauci,et al. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. , 1990, Immunology today.
[93] R. Gallo,et al. Hydrocortisone and some other hormones enhance the expression of HTLV‐III , 1986, International journal of cancer.
[94] J. Justement,et al. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells , 1992, The Journal of experimental medicine.
[95] R. Abe,et al. Analysis of Mlsc genetics. A novel instance of genetic redundancy , 1989, The Journal of experimental medicine.
[96] C. Atkin,et al. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. , 1991, Immunology today.
[97] R. Gallo,et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[98] M. Dietrich,et al. ALTERED FOLLICULAR DENDRITIC CELLS AND VIRUS-LIKE PARTICLES IN AIDS AND AIDS-RELATED LYMPHADENOPATHY , 1985, The Lancet.
[99] R. Schooley,et al. RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO , 1985, The Lancet.
[100] P. J. Dyson,et al. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes , 1991, Nature.
[101] S. Nakamura,et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.
[102] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[103] O. Bagasra,et al. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. , 1992, The New England journal of medicine.
[104] R. Zinkernagel,et al. T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens , 1988, Nature.
[105] A. Fauci,et al. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[106] S. J. Clark,et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.
[107] H. Robson MacDonald,et al. Clonal deletion of V β814-bearing T cells in mice transgenic for mammary tumour virus , 1991, Nature.
[108] E. Palmer,et al. An endogenous retrovirus mediating deletion of αβ T cells? , 1991, Nature.
[109] S W Lagakos,et al. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .
[110] A. Fauci,et al. Induction of expression of HIV in latently or chronically infected cells. , 1989, AIDS research and human retroviruses.
[111] D. Abrams,et al. Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? , 1984, Annals of internal medicine.
[112] B. Nathwani,et al. Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. , 1989, The American journal of pathology.
[113] Gwyn T. Williams,et al. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures , 1989, Nature.
[114] J. Justement,et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.
[115] M. Newell,et al. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen , 1990, Nature.
[116] J. Seigneurin,et al. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. , 1992, AIDS research and human retroviruses.
[117] R. Orentas,et al. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. , 1989, Science.
[118] G. Schiavo,et al. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. , 1992, Journal of immunology.
[119] A. Fauci,et al. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells , 1990, Journal of virology.
[120] C. Kufta,et al. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. , 1990, Science.
[121] T. Holzer,et al. The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. , 1991, Disease markers.
[122] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[123] M. Dietrich,et al. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. , 1986, The American journal of pathology.
[124] M. McElrath,et al. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[125] G. Beall,et al. Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.
[126] M. Grieco,et al. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. , 1988, Journal of acquired immune deficiency syndromes.
[127] A. Fauci,et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[128] P. Marrack,et al. V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.
[129] J. Lifson,et al. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.
[130] M. Helbert. T-cell receptor variable gene products and early HIV-1 infection. , 1992 .
[131] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[132] J. McKeating,et al. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. , 1990, AIDS.
[133] L. Montagnier,et al. The cytopathic effect of HIV is associated with apoptosis. , 1991, Virology.
[134] S. Patterson,et al. Effect of Human Immunodeficiency Virus on Dendritic Cells Isolated from Human Peripheral Blood , 1989 .
[135] A. Capron,et al. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. , 1991, Immunology today.
[136] J. Justement,et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[137] J. Chermann,et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.
[138] R. Garry,et al. Potential mechanisms for the cytopathic properties of HIV. , 1989, AIDS.
[139] H. Balfour,et al. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. , 1991, Journal of immunology.
[140] M. Clerici,et al. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. , 1989, The Journal of clinical investigation.
[141] G. Morel,et al. Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. , 1990, Virology.
[142] L. Kingsley,et al. The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs. , 1992, Journal of acquired immune deficiency syndromes.
[143] J. Merrill,et al. HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[144] H. Schuitemaker,et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. , 1992, The Journal of clinical investigation.
[145] J. Laurence,et al. Effect of Glucocorticoids on Chronic Human Immunodeficiency Virus (HIV) Infection and HIV Promoter-Mediated Transcription , 1989 .
[146] E. Gelmann,et al. The Acquired Immunodeficiency Syndrome: An Update , 1985 .
[147] D. Bolognesi. HIV antibodies and vaccine design , 1989, AIDS.
[148] C H Fox,et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.
[149] J. Justement,et al. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage , 1991, The Journal of experimental medicine.
[150] T. Schulz,et al. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? , 1991, AIDS research and human retroviruses.
[151] H. Mitsuya,et al. Molecular targets for AIDS therapy. , 1990, Science.
[152] K. Frei,et al. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.
[153] H. Rammensee,et al. Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells , 1989, Nature.
[154] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[155] A. Fauci,et al. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[156] M. Roederer,et al. N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.
[157] B. Spire,et al. Induction of NF-KB during monocyte differentiation by HIV type 1 infection. , 1991, Journal of immunology.
[158] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[159] J. Sprent,et al. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.
[160] M. Gardner,et al. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. , 1986, Journal of interferon research.
[161] C. Fox,et al. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. , 1991, The Journal of infectious diseases.
[162] J. Justement,et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms , 1990, The Journal of experimental medicine.
[163] A. Fauci,et al. Immunopathogenesis of HIV infection , 1991, Journal of acquired immune deficiency syndromes.